Bone marrow edema-like signal after cartilage repair does not affect outcomes in a five-year follow-up - Scorecard - MDSpire

Bone marrow edema-like signal after cartilage repair does not affect outcomes in a five-year follow-up

  • By

  • Felix R. M. Koenig

  • Marcus Raudner

  • Vladimir Juras

  • Pavol Szomolanyi

  • Veronika Vetchy

  • Jakob Kittinger

  • Ehsan Safai Zadeh

  • Martin L. Watzenböck

  • Siegfried Trattnig

  • September 16, 2024

  • 0 min

Share

Clinical Scorecard: Impact of Bone Marrow Edema-Like Signals on Outcomes Following Cartilage Repair: A Five-Year Follow-Up Study

At a Glance

CategoryDetail
ConditionCartilage lesions of the knee and associated bone marrow edema-like signals (BMELS)
Key MechanismsBMELS represent subchondral hyperintensities observed after cartilage repair, potentially reflecting physiological healing or pathological changes leading to osteophyte and cyst formation
Target PopulationPatients undergoing cartilage repair of the knee via microfracturing (MFX) or matrix-induced autologous chondrocyte implantation (MACI)
Care SettingOrthopedic and musculoskeletal clinical settings with MRI imaging follow-up

Key Highlights

  • BMELS are common findings post cartilage repair and may either resolve or persist, influencing long-term outcomes.
  • Persistence or atypical progression of BMELS may be associated with poorer morphological and clinical outcomes.
  • MRI with T2 mapping and MOCART 2.0 scoring provides reproducible assessment of cartilage repair and BMELS over a 5-year follow-up.

Guideline-Based Recommendations

Diagnosis

  • Use fat-suppressed proton density MRI sequences in the coronal plane to identify BMELS.
  • Perform T2 mapping with standardized ROI placement to assess cartilage repair tissue quality.
  • Classify BMELS by size relative to repair tissue diameter using MOCART 2.0 criteria.

Management

  • Recognize that early postoperative BMELS may represent physiological healing; monitor progression over time.
  • Consider persistent or enlarging BMELS as potential indicators of suboptimal repair and risk for osteoarthritis development.
  • Employ clinical scores such as KOOS and subjective IKDC for patient-reported outcome monitoring.

Monitoring & Follow-up

  • Schedule MRI follow-ups at 3, 12, and 60 months post cartilage repair to evaluate BMELS dynamics and cartilage morphology.
  • Use interrater reliable imaging assessments to track lesion size and characteristics longitudinally.
  • Correlate imaging findings with clinical outcome scores to guide prognosis.

Risks

  • Long-term persistence of BMELS may lead to osteophyte and subchondral cyst formation.
  • Absence of BMELS in early postoperative phase might indicate poorer healing response.
  • Atypical BMELS progression patterns are associated with worse morphological and clinical outcomes.

Patient & Prescribing Data

45 patients undergoing knee cartilage repair with MFX or MACI, followed for 5 years

Both MFX and MACI patients exhibit BMELS postoperatively; BMELS size and progression correlate with cartilage repair quality and clinical outcomes, informing prognosis and follow-up strategies.

Clinical Best Practices

  • Obtain informed consent and adhere to ethical standards including Declaration of Helsinki in clinical studies.
  • Use standardized MRI protocols and validated scoring systems (MOCART 2.0) for consistent assessment.
  • Perform longitudinal imaging and clinical evaluations to monitor healing and detect adverse BMELS progression.
  • Interpret BMELS in context of timing post-surgery, recognizing early BMELS as potentially physiological.
  • Integrate imaging findings with patient-reported outcome measures for comprehensive assessment.

References

Original Source(s)

Related Content